ASML Faces a Tale of Two Tailwinds: India’s First Fab and Europe’s €120 Billion Pledge

The Dutch lithography giant closed the final week of May at €1,388.60, a modest 0.73 per cent advance that keeps it tantalisingly close to its 52?week peak of €1,420.80. Year?to?date the stock has surged more than 40 per cent, yet this rally has done little to settle the growing debate over whether ASML’s valuation has run ahead of fundamentals. With two very different catalysts now on the table — a landmark deal in India and a fresh €120 billion push from Brussels — the conversation is only getting louder.

India’s Bet on Chip Sovereignty

ASML has signed a partnership with Tata Electronics to supply lithography systems for India’s first major front?end semiconductor fab, a 300?millimetre wafer plant in the state of Gujarat. The agreement goes well beyond hardware: it includes staff training, supply?chain integration and joint research. For a company whose revenue has long concentrated in Taiwan and South Korea, this marks a genuine pivot. India offers a government?backed chip programme and a market with virtually no incumbent competition. Analysts see a long?term growth lever, but warn that infrastructure bottlenecks and regulatory hurdles could slow the build?out.

Europe Doubles Down on Chip Strategy

Just days later, reports emerged that the European Union is preparing a “Chips Act 2.0” targeting up to €120 billion in public and private investment by 2035. Unlike the original 2023 legislation, the new version shifts emphasis towards the demand side: key industries such as automotive, telecommunications and defence will be deliberately linked to domestic chipmakers. For ASML, the initiative cuts both ways. It reinforces the company’s systemic importance as the sole supplier of the high?end EUV lithography tools required for the most advanced chips. But heightened regulatory focus on critical supply chains could also bring new compliance costs.

Should investors sell immediately? Or is it worth buying Asml?

The Valuation Knife?Edge

The stock currently trades at roughly 52 times trailing twelve?month earnings, some 32 per cent above its five?year average. Some independent valuation models peg fair value at around $1,096, well below the current level. The relative strength index sits at a neutral 49.6, suggesting the market is neither overstretched nor oversold.

The analyst community mirrors this split. UBS raised its price target sharply from €1,600 to €1,900, citing sustained AI?infrastructure demand and ASML’s near?monopoly in EUV. RBC maintains an “Outperform” with a $1,700 target. On the other side, Morningstar rates the stock a sell, while Weiss Ratings downgraded it from “buy” to “hold”. Of the 32 analysts tracked, the consensus remains a moderate buy, driven largely by the EUV moat.

Capital Returns and Guidance

ASML continues to return cash to shareholders, spending roughly €1.1 billion on share buybacks in the first quarter of 2026. The full?year outlook calls for net revenue between €36 billion and €40 billion, with gross margins in the 51–53 per cent range. Whether that guidance can justify the current premium will depend heavily on how quickly India’s Gujarat fab ramps up and on the precise details of the EU Chips Act 2.0 — details that are expected to emerge in the coming months.

Ad

Asml Stock: New Analysis - 30 May

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

en | NL0010273215 | ASML | boerse | 69449846 |